Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin added to insulin ± metformin in Chinese type 2 diabetes mellitus
CTR20160560Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of linagliptin in type 2 diabetes mellitus (T2DM), sponsored by Boehringer Ingelheim. Started Aug 2016; status: completed.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20160560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160560.